SCOLR Pharma, Inc. (SCLR) [Rocket]

In millions, except per share items	Sep-30-11	Jun-30-11	Mar-31-11	Dec-31-10	Sep-30-10	Jun-30-10	Mar-31-10	Dec-31-09
	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K
Revenues
Licensing fees						0.1
Royalty income	0.0	0.0			0.1	0.1
Research and development	0.0	0.0			0.1	0.1
Total revenues	0.0	0.0	0.2	0.4	0.1	0.2	0.2	0.3
Total revenues growth	-90.3%	-96.4%	0.0%	55.7%	-52.7%	-3.5%	-3.5%	53.5%
Operating expenses
Marketing and selling	0.0	0.1			0.1	0.1
Research and development	0.1	-0.1			0.3	0.3
General and administrative	0.5	0.6			0.6	0.6
Total operating expenses	0.6	0.5			1.0	0.9
Loss from operations	-0.6	-0.5			-0.9	-0.7
Operating margin	-5025.0%	-6587.5%			-700.8%	-309.9%

Other income (expense)
Interest income	0.2	0.0
Interest expense	-0.2	0.0

Unrealized gain (loss) on fair value of warrant
Other	-0.2	0.0			-0.1	0.0
Total other (expense)	-0.2	0.0			-0.1	0.2
Net loss	-0.8	-0.5			-1.0	-0.5

Net loss per share, basic and diluted	($0.02)	($0.01)			($0.02)	($0.01)

Shares used in computing basic and diluted net loss per share	49.8	49.8			49.8	49.7